Education
About Us
Working with TipRanks
Follow Us
AstraZeneca PLC (AZN)
NYSE:AZN
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 58.74B | $ 52.94B | $ 46.58B | $ 44.25B | $ 37.11B |
| Gross Profit | $ 48.11B | $ 39.70B | $ 34.45B | $ 28.04B | $ 22.60B |
| Operating Income | $ 13.74B | $ 12.52B | $ 9.57B | $ 5.05B | $ 2.81B |
| EBITDA | $ 19.83B | $ 14.86B | $ 13.20B | $ 8.63B | $ 4.59B |
| Net Income | $ 10.22B | $ 6.89B | $ 6.06B | $ 3.28B | $ 109.85M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 5.74B | $ 5.65B | $ 5.91B | $ 6.24B | $ 6.37B |
| Total Assets | $ 114.07B | $ 104.03B | $ 101.12B | $ 96.48B | $ 105.36B |
| Total Debt | $ 29.62B | $ 30.11B | $ 28.41B | $ 29.14B | $ 30.69B |
| Net Debt | $ 23.91B | $ 24.63B | $ 22.57B | $ 22.98B | $ 24.36B |
| Total Liabilities | $ 65.36B | $ 63.16B | $ 61.95B | $ 59.42B | $ 66.08B |
| Stockholders' Equity | $ 48.67B | $ 40.79B | $ 39.14B | $ 37.04B | $ 39.27B |
| Cash Flow | |||||
| Free Cash Flow | $ 8.67B | $ 7.28B | $ 6.57B | $ 7.24B | $ 3.76B |
| Operating Cash Flow | $ 14.57B | $ 11.86B | $ 10.35B | $ 9.81B | $ 5.96B |
| Investing Cash Flow | $ -6.81B | $ -7.98B | $ -4.06B | $ -2.96B | $ -11.06B |
| Financing Cash Flow | $ -7.54B | $ -4.00B | $ -6.57B | $ -6.82B | $ 3.65B |